Cleared Traditional

K173444 - Quantitative Total Extensible Imaging (...

K173444 is the FDA 510(k) clearance for Quantitative Total Extensible Imaging (... by Aiq Solutions, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 259-day FDA review.

K173444 · Aiq Solutions, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2018
Decision
259d
Days
Class 2
Risk

K173444 is an FDA 510(k) clearance for the Quantitative Total Extensible Imaging (QTxI). Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Aiq Solutions, Inc. (Madison, US). The FDA issued a Cleared decision on July 23, 2018 after a review of 259 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Aiq Solutions, Inc. devices

Submission Details

510(k) Number K173444 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 2017
Decision Date July 23, 2018
Days to Decision 259 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
152d slower than avg
Panel avg: 107d · This submission: 259d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Epireg, LLC
Mitch Lewandowski

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1096
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K173444.
CubeVue
K181962 · Curvebeam, LLC · Aug 2018
VirtuOst Vertebral Fracture Assessment
K171435 · O.N. Diagnostics, LLC · Aug 2018
miPlatform medical imaging suite v3.0 (miPlatform v3.0), miPlatform ZFP Viewer
K171977 · Hinacom Software and Technology, Ltd. · Aug 2018
DentiqGuide
K180629 · 3D Industrial Imaging Co., Ltd. · Jul 2018
Ceevra Reveal 2.0
K173274 · Ceevra, Inc. · Jul 2018
DenSeeMammo
K173574 · Statlife · Jun 2018